Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Alector, Inc. of shares of its common stock for up to a maximum offering price of $150 million.
Headquartered in South San Francisco, California, Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration.
The Davis Polk corporate team included partners Alan F. Denenberg and Stephen Salmon and associate Kimberly Wang. Partner Frank J. Azzopardi and associate Hilary Smith provided intellectual property advice. The tax team included counsel Leslie J. Altus and associate Rebecca A. Rosen. Counsel Marcie A. Goldstein provided FINRA advice. Associate Sijia Cai provided 1940 Act advice. Members of the Davis Polk team are based in the Northern California and New York offices.